CONMED Corporation revised earnings guidance for the full year 2024. For the period, the company's revenue is expected to be between $1.330 billion and $1.355 billion, compared to the prior guidance range of between $1.340 billion and $1.365 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.16 USD | +1.17% | -0.84% | -35.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.02% | 2.17B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2024